UniProt | Protein Name |
---|---|
O15528 |
|
GO Term | Evidence Code | PMID |
---|---|---|
calcium ion transport | ||
negative regulation of calcidiol 1-monooxygenase activity | ||
G1 to G0 transition | ||
response to estrogen | ||
response to lipopolysaccharide |
GO Term | Evidence Code | PMID |
---|---|---|
cytoplasm | ||
mitochondrial outer membrane |
|
|
mitochondrion |
GO Term | Evidence Code | PMID |
---|---|---|
iron ion binding | ||
secalciferol 1-monooxygenase activity | ||
calcidiol 1-monooxygenase activity | ||
heme binding |
DO ID | Disease Name | Source |
---|---|---|
DOID:0110759 | type 1 diabetes mellitus 22 | |
DOID:0110760 | type 1 diabetes mellitus 23 | |
DOID:0110761 | type 1 diabetes mellitus 24 | |
DOID:0110892 | inflammatory bowel disease 1 | |
DOID:10041 | dysplastic nevus syndrome | |
DOID:10283 | prostate cancer | |
DOID:10286 | prostate carcinoma | |
DOID:104 | bacterial infectious disease | |
DOID:10493 | adrenal cortical hypofunction | |
DOID:10573 | osteomalacia |
HPO ID | HPO Term |
---|---|
HP:0002752 | Sparse bone trabeculae |
HP:0002753 | Thin bony cortex |
HP:0002757 | Recurrent fractures |
HP:0002901 | Hypocalcemia |
HP:0002909 | Generalized aminoaciduria |
HP:0002970 | Genu varum |
HP:0002979 | Bowing of the legs |
HP:0002980 | Femoral bowing |
HP:0002982 | Tibial bowing |
HP:0003013 | Bulging epiphyses |
Disease ID | Disease Name |
---|---|
OMIM:264700 |
|
ORPHA:289157 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
173936 | WB:WBGene00000375 | ||
36105 | FB:FBgn0033524 | ||
36378 | FB:FBgn0033753 | ||
37163 | FB:FBgn0034387 | ||
40037 | FB:FBgn0036806 | ||
41272 | FB:FBgn0037817 | ||
42293 | FB:FBgn0038680 | ||
42294 | FB:FBgn0038681 | ||
246648 | FB:FBgn0050489 | ||
2768720 | FB:FBgn0053503 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024